版本:
中国

BRIEF-Cellectis Announces the Issuance of US Patent 9,458,439

Oct 5 Cellectis SA :

* Announced on Tuesday the issuance of U.S. patent 9,458,439 - which claims gene inactivation by use of chimeric restriction endonucleases

* This patent granted by the USPTO to the Institut Pasteur and Boston Children's Hospital naming Dr Andre Choulika and Pr. Richard C. Mulligan as co-inventors, is exclusively licensed to Cellectis

Source text for Eikon: Further company coverage:

(Gdynia Newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐